Orchid Pharma has announced the appointment of Dr. Prabhu Vinayagam as Medical Advisor for its newly established division, Orchid AMS. This strategic move aims to bolster the company’s efforts in antimicrobial stewardship (AMS) and enhance its capabilities in combating antimicrobial resistance (AMR).
Dr. Vinayagam brings a wealth of experience in healthcare leadership and antimicrobial stewardship to Orchid AMS. His extensive career includes pivotal roles at Becton Dickinson, where he made significant contributions as Managing Director of Joint Commission International – Asia Pacific, and as Group CEO at Mandalar Group of Hospitals in Myanmar. His deep understanding of hospital operations, quality improvement practices, and data-driven decision-making will be crucial in optimizing antibiotic use and reducing hospital-acquired infections (HAIs).
In his advisory role, Dr. Vinayagam’s expertise in strategic acumen and operational leadership will be instrumental in driving Orchid Pharma’s AMS initiatives. His proven track record in implementing quality improvement practices and reducing HAIs positions him uniquely to spearhead the company’s efforts in this critical area.
Rajnish Rohatgi, CEO of Orchid AMS, expressed his enthusiasm about Dr. Vinayagam’s appointment, stating, “We are all set to move the needle for AMR management in India, for which we need a solid, highly skilled, and self-driven team. Dr. Prabhu’s extensive experience and knowledge will be invaluable in building a unique basket of solutions that help hospitals address AMR more fully.”
Orchid Pharma, established in 1992 and based in Chennai, India, is a leading pharmaceutical company with expertise spanning the entire value chain from discovery to delivery. The company’s focus on research, manufacturing, and marketing has established its credentials as a vertically integrated pharmaceutical entity.
Dr. Vinayagam’s appointment marks a significant step forward for Orchid AMS in its mission to combat antimicrobial resistance and enhance patient care through optimized antibiotic use.
